CREBBP and lung carcinoma: With the aim of improving therapeutic attempts for lung cancer harboring KRAS mutant, we found a multi-functional transcription factor inhibitor named Naphthol AS-TR phosphate (NASTRp), targeting the CREB-CBP complex, as a potent anti-cancer agent for lung cancer.